Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | AMGN | VRTX | BMY | GILD |
| Company | Regeneron Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1,199.34 | 328.42 | 482.76 | 48.36 | 77.21 |
| High | 1,211.20 | 329.83 | 483.45 | 48.79 | 77.46 |
| Low | 1,197.13 | 325.58 | 476.38 | 47.81 | 76.69 |
| Last | 1,201.76 | 326.93 | 480.30 | 48.12 | 77.00 |
| Change | +2.39 | +0.15 | -2.34 | -0.12 | +0.04 |
| % Change | +0.20% | +0.05% | -0.48% | -0.25% | +0.05% |
| Volume | 295,483 | 1,444,306 | 1,062,157 | 6,917,940 | 3,901,698 |
| 20-Day Average Volume | 484,544 | 2,024,300 | 1,242,493 | 12,534,187 | 5,454,835 |
| Previous Close | 1,199.37 | 326.78 | 482.64 | 48.24 | 76.96 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1,142.88 | 326.08 | 479.30 | 48.06 | 75.09 |
| 20-Day Raw Stochastic | 94.43% | 59.30% | 42.32% | 49.61% | 79.07% |
| 20-Day Relative Strength | 72.49% | 52.44% | 50.87% | 57.01% | 62.14% |
| Weighted Alpha | +51.29 | +27.13 | +35.85 | -17.03 | +3.82 |
| Today's Opinion | 100% Buy | 88% Buy | 56% Buy | 40% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 72% Buy | 40% Buy | 72% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 8% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.80% since 08/20/24 | -0.49% since 08/20/24 | -1.45% since 08/20/24 | -1.76% since 08/20/24 | +3.01% since 08/20/24 |
| Low | 1,180.00 on 08/22/24 | 323.12 on 08/22/24 | 476.38 on 08/27/24 | 46.88 on 08/22/24 | 74.80 on 08/21/24 |
| High | 1,211.20 on 08/27/24 | 331.29 on 08/23/24 | 491.88 on 08/21/24 | 49.17 on 08/21/24 | 77.46 on 08/27/24 |
| 1-Month | |||||
| %Chg | +11.42% since 07/26/24 | -2.37% since 07/26/24 | -3.02% since 07/26/24 | -4.62% since 07/26/24 | -0.01% since 07/26/24 |
| Low | 1,041.85 on 08/01/24 | 306.59 on 08/07/24 | 458.04 on 08/13/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 1,211.20 on 08/27/24 | 340.89 on 08/01/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 | 78.45 on 07/30/24 |
| 3-Month | |||||
| %Chg | +22.00% since 05/24/24 | +6.90% since 05/24/24 | +5.11% since 05/24/24 | +16.68% since 05/24/24 | +17.24% since 05/24/24 |
| Low | 952.30 on 05/30/24 | 295.30 on 06/13/24 | 435.57 on 05/30/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 1,211.20 on 08/27/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 | 78.45 on 07/30/24 |
| 6-Month | |||||
| %Chg | +20.98% since 02/27/24 | +17.39% since 02/27/24 | +11.46% since 02/27/24 | -4.73% since 02/27/24 | +5.45% since 02/27/24 |
| Low | 875.22 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 1,211.20 on 08/27/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 55.03 on 03/13/24 | 78.45 on 07/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 132,153,768 | 175,296,224 | 124,546,712 | 97,787,312 | 95,880,848 |
| Shares Outstanding, K | 110,186 | 536,435 | 258,053 | 2,027,100 | 1,245,853 |
| Annual Sales | 13,117,200,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | 3,953,600,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 3,547,100,000 | 8,388,000,000 | 2,645,600,000 | 12,201,000,000 | 6,954,000,000 |
| Last Quarter Net Income | 1,432,300,000 | 746,000,000 | -3,593,600,000 | 1,680,000,000 | 1,614,000,000 |
| 60-Month Beta | 0.13 | 0.58 | 0.39 | 0.44 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | 11.56 on 08/01/24 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 08/01/24 | 08/06/24 | 08/01/24 | 07/26/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 07/05/24 | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | 07/05/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 31.21 | 17.68 | 0.00 | 35.12 | 16.32 |